

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 8.15764421 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 8.15764421 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 8.15764421 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 8.15764421 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 8.15764421 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 8.15764421 |
| 7 | response to peptidoglycan (GO:0032494) | 5.91022668 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.69159519 |
| 9 | response to host immune response (GO:0052572) | 5.45419110 |
| 10 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.45419110 |
| 11 | microglial cell activation (GO:0001774) | 5.34112218 |
| 12 | cellular response to interferon-alpha (GO:0035457) | 5.23036976 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 5.12569083 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 5.00215184 |
| 15 | adhesion of symbiont to host cell (GO:0044650) | 4.90041045 |
| 16 | virion attachment to host cell (GO:0019062) | 4.90041045 |
| 17 | response to host (GO:0075136) | 4.86023960 |
| 18 | response to host defenses (GO:0052200) | 4.86023960 |
| 19 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.86023960 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.84970617 |
| 21 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.82721607 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.72527894 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.63340788 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.47791072 |
| 25 | response to interferon-alpha (GO:0035455) | 4.43460505 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39904047 |
| 27 | cellular response to type I interferon (GO:0071357) | 4.30594614 |
| 28 | type I interferon signaling pathway (GO:0060337) | 4.30594614 |
| 29 | response to type I interferon (GO:0034340) | 4.29976762 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.27634300 |
| 31 | positive regulation of interferon-beta production (GO:0032728) | 4.12101887 |
| 32 | regulation of mononuclear cell migration (GO:0071675) | 4.10037062 |
| 33 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.09984099 |
| 34 | eosinophil chemotaxis (GO:0048245) | 4.08801102 |
| 35 | positive regulation of heat generation (GO:0031652) | 4.06124013 |
| 36 | adhesion of symbiont to host (GO:0044406) | 4.05416919 |
| 37 | lymphocyte chemotaxis (GO:0048247) | 4.04205852 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 4.01487094 |
| 39 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.01029926 |
| 40 | macrophage activation (GO:0042116) | 3.96858526 |
| 41 | regulation of fever generation (GO:0031620) | 3.95832589 |
| 42 | regulation of chemokine biosynthetic process (GO:0045073) | 3.84530402 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.80660068 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.80526936 |
| 45 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.79023002 |
| 46 | monocyte chemotaxis (GO:0002548) | 3.78309210 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.75350953 |
| 48 | negative regulation of viral genome replication (GO:0045071) | 3.69447662 |
| 49 | granulocyte activation (GO:0036230) | 3.69137330 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67208831 |
| 51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.67208831 |
| 52 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.66628440 |
| 53 | positive regulation of macrophage cytokine production (GO:0060907) | 3.63859926 |
| 54 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.60204731 |
| 55 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.58742478 |
| 56 | cellular extravasation (GO:0045123) | 3.58544641 |
| 57 | eosinophil migration (GO:0072677) | 3.55198710 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.53880949 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.53796268 |
| 60 | I-kappaB phosphorylation (GO:0007252) | 3.50631322 |
| 61 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.49603700 |
| 62 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.48926386 |
| 63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43350868 |
| 64 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.42261278 |
| 65 | negative regulation of interleukin-17 production (GO:0032700) | 3.41310925 |
| 66 | regulation of hypersensitivity (GO:0002883) | 3.39819782 |
| 67 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.38564515 |
| 68 | cellular response to exogenous dsRNA (GO:0071360) | 3.37005892 |
| 69 | positive regulation of antigen processing and presentation (GO:0002579) | 3.33813666 |
| 70 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.30833712 |
| 71 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.30328465 |
| 72 | respiratory burst (GO:0045730) | 3.30028288 |
| 73 | regulation of podosome assembly (GO:0071801) | 3.29841234 |
| 74 | T cell migration (GO:0072678) | 3.29723970 |
| 75 | positive regulation of lymphocyte migration (GO:2000403) | 3.28153997 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24749928 |
| 77 | amino sugar catabolic process (GO:0046348) | 3.24415905 |
| 78 | decidualization (GO:0046697) | 3.21862261 |
| 79 | positive regulation of type 2 immune response (GO:0002830) | 3.20888534 |
| 80 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.20052739 |
| 81 | neutrophil activation (GO:0042119) | 3.19810995 |
| 82 | positive regulation of chemokine production (GO:0032722) | 3.17341233 |
| 83 | keratan sulfate catabolic process (GO:0042340) | 3.14285698 |
| 84 | cellular response to interferon-beta (GO:0035458) | 3.12719064 |
| 85 | apoptotic cell clearance (GO:0043277) | 3.12451234 |
| 86 | reactive oxygen species biosynthetic process (GO:1903409) | 3.11747032 |
| 87 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.10438638 |
| 88 | regulation of apoptotic cell clearance (GO:2000425) | 3.08932382 |
| 89 | negative regulation of growth of symbiont in host (GO:0044130) | 3.07006842 |
| 90 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.07006842 |
| 91 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.07006842 |
| 92 | regulation of growth of symbiont in host (GO:0044126) | 3.07006842 |
| 93 | superoxide anion generation (GO:0042554) | 3.05795586 |
| 94 | regulation of heat generation (GO:0031650) | 3.04537109 |
| 95 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.02134778 |
| 96 | oligosaccharide catabolic process (GO:0009313) | 3.02026986 |
| 97 | glycosphingolipid catabolic process (GO:0046479) | 3.01465287 |
| 98 | negative regulation of interleukin-12 production (GO:0032695) | 2.98748931 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98389880 |
| 100 | B cell mediated immunity (GO:0019724) | 2.95151850 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.94175712 |
| 102 | positive regulation of interleukin-12 production (GO:0032735) | 2.93497399 |
| 103 | barbed-end actin filament capping (GO:0051016) | 2.93430521 |
| 104 | regulation of interleukin-17 production (GO:0032660) | 2.92362257 |
| 105 | regulation of vitamin metabolic process (GO:0030656) | 2.92323329 |
| 106 | regulation of interferon-beta production (GO:0032648) | 2.89748367 |
| 107 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.89643490 |
| 108 | negative regulation of lipid storage (GO:0010888) | 2.89508257 |
| 109 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.89147090 |
| 110 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.88014332 |
| 111 | regulation of macrophage cytokine production (GO:0010935) | 2.87552535 |
| 112 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.87033916 |
| 113 | cellular response to virus (GO:0098586) | 2.87024449 |
| 114 | regulation of type 2 immune response (GO:0002828) | 2.87008195 |
| 115 | regulation of antigen processing and presentation (GO:0002577) | 2.86684548 |
| 116 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.85974599 |
| 117 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.85531651 |
| 118 | cellular response to lipopolysaccharide (GO:0071222) | 2.84598426 |
| 119 | response to interferon-beta (GO:0035456) | 2.81929686 |
| 120 | positive regulation of interleukin-6 production (GO:0032755) | 2.81884662 |
| 121 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.81388838 |
| 122 | cellular response to molecule of bacterial origin (GO:0071219) | 2.80316094 |
| 123 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.79997878 |
| 124 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.77855294 |
| 125 | glucosamine-containing compound catabolic process (GO:1901072) | 2.75881680 |
| 126 | positive regulation of acute inflammatory response (GO:0002675) | 2.75217620 |
| 127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.72777708 |
| 128 | glycolipid catabolic process (GO:0019377) | 2.68609011 |
| 129 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.67195190 |
| 130 | cellular response to ethanol (GO:0071361) | 2.66930342 |
| 131 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61380945 |
| 132 | negative regulation of type 2 immune response (GO:0002829) | 2.60259658 |
| 133 | regulation of chronic inflammatory response (GO:0002676) | 2.59619364 |
| 134 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59463800 |
| 135 | regulation of immunoglobulin secretion (GO:0051023) | 2.58283255 |
| 136 | positive regulation of cholesterol efflux (GO:0010875) | 2.56112767 |
| 137 | adenosine receptor signaling pathway (GO:0001973) | 2.55660844 |
| 138 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.54774032 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.54222011 |
| 140 | regulation of monocyte differentiation (GO:0045655) | 2.53951511 |
| 141 | regulation of macrophage chemotaxis (GO:0010758) | 2.51825161 |
| 142 | positive regulation of phagocytosis (GO:0050766) | 2.50546191 |
| 143 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.49464267 |
| 144 | regulation of cholesterol storage (GO:0010885) | 2.47305662 |
| 145 | pinocytosis (GO:0006907) | 2.46840783 |
| 146 | positive regulation of bone remodeling (GO:0046852) | 2.46751348 |
| 147 | positive regulation of bone resorption (GO:0045780) | 2.46751348 |
| 148 | myeloid dendritic cell activation (GO:0001773) | 2.45585896 |
| 149 | osteoclast differentiation (GO:0030316) | 2.44831638 |
| 150 | regulation of germinal center formation (GO:0002634) | 2.44766084 |
| 151 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.44169149 |
| 152 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.42918539 |
| 153 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42685167 |
| 154 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.41409336 |
| 155 | regulation of axon regeneration (GO:0048679) | 2.38275608 |
| 156 | regulation of neuron projection regeneration (GO:0070570) | 2.38275608 |
| 157 | iron ion import (GO:0097286) | 2.37419747 |
| 158 | ceramide catabolic process (GO:0046514) | 2.37057418 |
| 159 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.36435802 |
| 160 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.35536219 |
| 161 | positive regulation of tissue remodeling (GO:0034105) | 2.35313810 |
| 162 | negative regulation of granulocyte differentiation (GO:0030853) | 2.34848546 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34668478 |
| 164 | granulocyte chemotaxis (GO:0071621) | 2.31151201 |
| 165 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.31039956 |
| 166 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.29304120 |
| 167 | dendritic cell differentiation (GO:0097028) | 2.28922810 |
| 168 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.28543729 |
| 169 | cellular response to interferon-gamma (GO:0071346) | 2.26571229 |
| 170 | regulation of T cell tolerance induction (GO:0002664) | 2.24987984 |
| 171 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.23235175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.40302060 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.67579133 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.76104313 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.06360856 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.25734568 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82785299 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71802414 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.56298394 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47974289 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.41595786 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.29846643 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.27779164 |
| 13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.14347153 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71348091 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.58146127 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39536697 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37217009 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36415494 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35723072 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30251404 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.26447227 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98284453 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96212817 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94923259 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88506780 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71143020 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69808708 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69161192 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67547040 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64794763 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59330167 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56632724 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55564514 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50415656 |
| 35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48582238 |
| 36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46763052 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43347934 |
| 38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.41343663 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40844389 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.39894083 |
| 41 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38610866 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35422756 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33395151 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30186273 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29596868 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28736989 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28486491 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28077685 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25503504 |
| 50 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25409763 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20214236 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18875823 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18875823 |
| 54 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18839675 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14809268 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12036299 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10303230 |
| 58 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06935914 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06059984 |
| 60 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05766770 |
| 61 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05381413 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04793254 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.02648606 |
| 64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01544603 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00973666 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.00430901 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97760991 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97739145 |
| 69 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96420679 |
| 70 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95916070 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95847789 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95847789 |
| 73 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94972103 |
| 74 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94727583 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94350941 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94180815 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92947759 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92538834 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92500665 |
| 80 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.92407065 |
| 81 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91449511 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91292658 |
| 83 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90638742 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90392287 |
| 85 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.89747956 |
| 86 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.89747956 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88981505 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 0.88898121 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87938802 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87266559 |
| 91 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.86605110 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86065259 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85577539 |
| 94 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84772445 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83472970 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82267890 |
| 97 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.81434113 |
| 98 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.79504695 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78546575 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78352145 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76605071 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76317633 |
| 103 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76125850 |
| 104 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76011601 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.75622628 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.75405082 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.74922563 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74843008 |
| 109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74292007 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74056497 |
| 111 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.73958974 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73570528 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.70759614 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69792687 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.69649671 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68288579 |
| 117 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.68156109 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65257723 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.62367949 |
| 120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.62256424 |
| 121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61090104 |
| 122 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60362530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.44390734 |
| 2 | MP0003436_decreased_susceptibility_to | 4.13731211 |
| 3 | MP0009785_altered_susceptibility_to | 3.92284464 |
| 4 | MP0006082_CNS_inflammation | 3.79362114 |
| 5 | MP0003724_increased_susceptibility_to | 3.53462898 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.40813537 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.40175161 |
| 8 | MP0004510_myositis | 3.10293463 |
| 9 | MP0002419_abnormal_innate_immunity | 2.98623540 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.96348036 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.95466690 |
| 12 | MP0005025_abnormal_response_to | 2.71045251 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.69051621 |
| 14 | MP0005387_immune_system_phenotype | 2.61011770 |
| 15 | MP0001790_abnormal_immune_system | 2.61011770 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.49986872 |
| 17 | MP0009764_decreased_sensitivity_to | 2.35888269 |
| 18 | MP0009840_abnormal_foam_cell | 2.29185344 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.28520945 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.18453608 |
| 21 | MP0002723_abnormal_immune_serum | 2.18199674 |
| 22 | MP0003075_altered_response_to | 2.09442882 |
| 23 | MP0001542_abnormal_bone_strength | 2.07319380 |
| 24 | MP0001800_abnormal_humoral_immune | 2.06279557 |
| 25 | MP0009278_abnormal_bone_marrow | 2.04680379 |
| 26 | MP0000685_abnormal_immune_system | 2.01555377 |
| 27 | MP0005503_abnormal_tendon_morphology | 2.01302917 |
| 28 | MP0004947_skin_inflammation | 2.00739310 |
| 29 | MP0003329_amyloid_beta_deposits | 1.99913165 |
| 30 | MP0000343_altered_response_to | 1.94919360 |
| 31 | MP0003448_altered_tumor_morphology | 1.87614048 |
| 32 | MP0001853_heart_inflammation | 1.79514713 |
| 33 | MP0001819_abnormal_immune_cell | 1.75800679 |
| 34 | MP0000604_amyloidosis | 1.72124303 |
| 35 | MP0008469_abnormal_protein_level | 1.71769001 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.71533164 |
| 37 | MP0003690_abnormal_glial_cell | 1.62666120 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.61960645 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.59785421 |
| 40 | MP0005671_abnormal_response_to | 1.58484199 |
| 41 | MP0002405_respiratory_system_inflammati | 1.55630823 |
| 42 | MP0005164_abnormal_response_to | 1.55517887 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.55278245 |
| 44 | MP0005166_decreased_susceptibility_to | 1.55275847 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.51243219 |
| 46 | MP0003195_calcinosis | 1.48632811 |
| 47 | MP0005595_abnormal_vascular_smooth | 1.46450273 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.41182578 |
| 49 | MP0005390_skeleton_phenotype | 1.40209160 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.37355598 |
| 51 | MP0002254_reproductive_system_inflammat | 1.36911556 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.36375669 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.33105833 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.30387851 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.30387851 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.28952846 |
| 57 | MP0005275_abnormal_skin_tensile | 1.28549964 |
| 58 | MP0006054_spinal_hemorrhage | 1.24521227 |
| 59 | MP0003828_pulmonary_edema | 1.21767222 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.20724537 |
| 61 | MP0001851_eye_inflammation | 1.20046998 |
| 62 | MP0004858_abnormal_nervous_system | 1.19845449 |
| 63 | MP0002006_tumorigenesis | 1.17242208 |
| 64 | MP0000858_altered_metastatic_potential | 1.14522359 |
| 65 | MP0000716_abnormal_immune_system | 1.12636405 |
| 66 | MP0003279_aneurysm | 1.11396841 |
| 67 | MP0004782_abnormal_surfactant_physiolog | 1.08674290 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.06794409 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.05287969 |
| 70 | MP0005023_abnormal_wound_healing | 1.04461758 |
| 71 | MP0003091_abnormal_cell_migration | 1.03352361 |
| 72 | MP0005310_abnormal_salivary_gland | 1.00554327 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.00336941 |
| 74 | MP0009763_increased_sensitivity_to | 0.99162089 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.98603853 |
| 76 | MP0002933_joint_inflammation | 0.96566501 |
| 77 | MP0003634_abnormal_glial_cell | 0.96566288 |
| 78 | MP0001958_emphysema | 0.95391667 |
| 79 | MP0002090_abnormal_vision | 0.91899814 |
| 80 | MP0010368_abnormal_lymphatic_system | 0.91692876 |
| 81 | MP0005508_abnormal_skeleton_morphology | 0.91344493 |
| 82 | MP0005647_abnormal_sex_gland | 0.91243893 |
| 83 | MP0002277_abnormal_respiratory_mucosa | 0.89948168 |
| 84 | MP0002398_abnormal_bone_marrow | 0.89690521 |
| 85 | MP0005377_hearing/vestibular/ear_phenot | 0.87655539 |
| 86 | MP0003878_abnormal_ear_physiology | 0.87655539 |
| 87 | MP0010307_abnormal_tumor_latency | 0.87265644 |
| 88 | MP0002971_abnormal_brown_adipose | 0.86928632 |
| 89 | MP0001243_abnormal_dermal_layer | 0.86646864 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.85094247 |
| 91 | MP0008874_decreased_physiological_sensi | 0.84995341 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.84688297 |
| 93 | MP0002429_abnormal_blood_cell | 0.83980949 |
| 94 | MP0000249_abnormal_blood_vessel | 0.83332481 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.83323424 |
| 96 | MP0003186_abnormal_redox_activity | 0.83188074 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.82721157 |
| 98 | MP0005083_abnormal_biliary_tract | 0.80806044 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.80524312 |
| 100 | MP0003879_abnormal_hair_cell | 0.80486798 |
| 101 | MP0005165_increased_susceptibility_to | 0.80320319 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.77317042 |
| 103 | MP0008004_abnormal_stomach_pH | 0.75801663 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.75205889 |
| 105 | MP0002166_altered_tumor_susceptibility | 0.74135511 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.73545577 |
| 107 | MP0004883_abnormal_blood_vessel | 0.73135471 |
| 108 | MP0003795_abnormal_bone_structure | 0.72071076 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.68965209 |
| 110 | MP0009115_abnormal_fat_cell | 0.68854560 |
| 111 | MP0001501_abnormal_sleep_pattern | 0.67735135 |
| 112 | MP0002722_abnormal_immune_system | 0.67020501 |
| 113 | MP0005365_abnormal_bile_salt | 0.66780487 |
| 114 | MP0001756_abnormal_urination | 0.66470895 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.66233185 |
| 116 | MP0003045_fibrosis | 0.64445471 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.64249913 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.63994237 |
| 119 | MP0000920_abnormal_myelination | 0.61465367 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.57591847 |
| 121 | MP0003941_abnormal_skin_development | 0.57200080 |
| 122 | MP0004272_abnormal_basement_membrane | 0.57115279 |
| 123 | MP0008873_increased_physiological_sensi | 0.54862123 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.54398638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.53571891 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.52217070 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.03763727 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.70327448 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.37802216 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.21875242 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 5.13347105 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.79559916 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.64704937 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.59672526 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.40294780 |
| 12 | Axonal loss (HP:0003447) | 4.31210165 |
| 13 | Basal ganglia calcification (HP:0002135) | 3.95890417 |
| 14 | Glomerulonephritis (HP:0000099) | 3.82732893 |
| 15 | Thick nail (HP:0001805) | 3.82027136 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.81348551 |
| 17 | Gingivitis (HP:0000230) | 3.80292933 |
| 18 | Disinhibition (HP:0000734) | 3.80137431 |
| 19 | Increased IgM level (HP:0003496) | 3.77346894 |
| 20 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.54960185 |
| 21 | Prostate neoplasm (HP:0100787) | 3.47865273 |
| 22 | Recurrent skin infections (HP:0001581) | 3.44395501 |
| 23 | Mutism (HP:0002300) | 3.35825070 |
| 24 | Stomatitis (HP:0010280) | 3.34428087 |
| 25 | Orchitis (HP:0100796) | 3.29283593 |
| 26 | Vasculitis (HP:0002633) | 3.21468446 |
| 27 | Dysostosis multiplex (HP:0000943) | 3.19875479 |
| 28 | Spondylolisthesis (HP:0003302) | 3.13074270 |
| 29 | Myocardial infarction (HP:0001658) | 3.09605067 |
| 30 | Myositis (HP:0100614) | 3.09135701 |
| 31 | Tetraparesis (HP:0002273) | 3.06017864 |
| 32 | Nephritis (HP:0000123) | 2.95407489 |
| 33 | Obstructive lung disease (HP:0006536) | 2.92063781 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92063781 |
| 35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90885207 |
| 36 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.88396615 |
| 37 | Osteolytic defects of the hand bones (HP:0009699) | 2.88396615 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.86358890 |
| 39 | Chronic otitis media (HP:0000389) | 2.86291361 |
| 40 | Agnosia (HP:0010524) | 2.85961535 |
| 41 | Hematochezia (HP:0002573) | 2.73955250 |
| 42 | Recurrent fungal infections (HP:0002841) | 2.73212216 |
| 43 | Optic neuritis (HP:0100653) | 2.70591058 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.70591058 |
| 45 | Esophageal neoplasm (HP:0100751) | 2.70580276 |
| 46 | Neoplasm of head and neck (HP:0012288) | 2.70580276 |
| 47 | Cellulitis (HP:0100658) | 2.68528483 |
| 48 | Periodontitis (HP:0000704) | 2.65289655 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.64114937 |
| 50 | Nausea (HP:0002018) | 2.58507541 |
| 51 | Urticaria (HP:0001025) | 2.57885037 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.57326148 |
| 53 | Nuclear cataract (HP:0100018) | 2.57121325 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.56699014 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56699014 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.56657964 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.55343656 |
| 58 | Recurrent viral infections (HP:0004429) | 2.54086069 |
| 59 | Porencephaly (HP:0002132) | 2.53578593 |
| 60 | Pustule (HP:0200039) | 2.44125000 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.41249487 |
| 62 | Loss of speech (HP:0002371) | 2.39632796 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.39584395 |
| 64 | Thin bony cortex (HP:0002753) | 2.39089680 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.36904275 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.36904275 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.36904275 |
| 68 | Joint stiffness (HP:0001387) | 2.35936906 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35310401 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35310401 |
| 71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35310401 |
| 72 | Aortic aneurysm (HP:0004942) | 2.35155763 |
| 73 | Cervical subluxation (HP:0003308) | 2.34142972 |
| 74 | Abnormality of complement system (HP:0005339) | 2.32416317 |
| 75 | Progressive visual loss (HP:0000529) | 2.31516759 |
| 76 | Pathologic fracture (HP:0002756) | 2.29304185 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.24961529 |
| 78 | Complement deficiency (HP:0004431) | 2.23624743 |
| 79 | Bone pain (HP:0002653) | 2.23403266 |
| 80 | Peritonitis (HP:0002586) | 2.23175529 |
| 81 | Osteomyelitis (HP:0002754) | 2.22963477 |
| 82 | Steatorrhea (HP:0002570) | 2.22935142 |
| 83 | Protuberant abdomen (HP:0001538) | 2.18722427 |
| 84 | Increased CSF protein (HP:0002922) | 2.17454911 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.16626184 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 2.16167258 |
| 87 | Nasal polyposis (HP:0100582) | 2.13713140 |
| 88 | Premature loss of primary teeth (HP:0006323) | 2.12965998 |
| 89 | Abnormality of the pericardium (HP:0001697) | 2.11266367 |
| 90 | Abnormality of the periventricular white matter (HP:0002518) | 2.11004918 |
| 91 | Poor head control (HP:0002421) | 2.09202924 |
| 92 | Apathy (HP:0000741) | 2.07710474 |
| 93 | Purpura (HP:0000979) | 2.04088236 |
| 94 | Distal lower limb muscle weakness (HP:0009053) | 2.00826949 |
| 95 | Abnormality of the costochondral junction (HP:0000919) | 2.00777906 |
| 96 | Parakeratosis (HP:0001036) | 2.00772987 |
| 97 | Diminished motivation (HP:0000745) | 1.99357945 |
| 98 | Recurrent pneumonia (HP:0006532) | 1.99129811 |
| 99 | Peripheral demyelination (HP:0011096) | 1.98404335 |
| 100 | Malnutrition (HP:0004395) | 1.96387996 |
| 101 | Amyloidosis (HP:0011034) | 1.96334629 |
| 102 | Neuronal loss in central nervous system (HP:0002529) | 1.94863042 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.94628900 |
| 104 | Xanthomatosis (HP:0000991) | 1.94115697 |
| 105 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.93972187 |
| 106 | Upper motor neuron abnormality (HP:0002127) | 1.93781833 |
| 107 | Neurofibrillary tangles (HP:0002185) | 1.93345871 |
| 108 | Ovoid vertebral bodies (HP:0003300) | 1.93212749 |
| 109 | Inappropriate behavior (HP:0000719) | 1.90806727 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 1.90390170 |
| 111 | Global brain atrophy (HP:0002283) | 1.89561273 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 1.89347438 |
| 113 | Leukocytosis (HP:0001974) | 1.88312723 |
| 114 | Petechiae (HP:0000967) | 1.87414524 |
| 115 | Emphysema (HP:0002097) | 1.86782362 |
| 116 | Arterial thrombosis (HP:0004420) | 1.86636272 |
| 117 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83327355 |
| 118 | Increased serum ferritin (HP:0003281) | 1.82099081 |
| 119 | Bone cyst (HP:0012062) | 1.79837688 |
| 120 | Premature rupture of membranes (HP:0001788) | 1.79079418 |
| 121 | Skin ulcer (HP:0200042) | 1.78998657 |
| 122 | Supranuclear gaze palsy (HP:0000605) | 1.78654274 |
| 123 | Vascular tortuosity (HP:0004948) | 1.78650208 |
| 124 | Recurrent lower respiratory tract infections (HP:0002783) | 1.78205208 |
| 125 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.76917095 |
| 126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.76917095 |
| 127 | Dilatation of the ascending aorta (HP:0005111) | 1.75983129 |
| 128 | Hemoptysis (HP:0002105) | 1.74621769 |
| 129 | T lymphocytopenia (HP:0005403) | 1.73274718 |
| 130 | Aortic dissection (HP:0002647) | 1.72902752 |
| 131 | Arthralgia (HP:0002829) | 1.72215883 |
| 132 | Abnormality of T cell number (HP:0011839) | 1.72169113 |
| 133 | Joint hemorrhage (HP:0005261) | 1.72119358 |
| 134 | Pulmonary hypertension (HP:0002092) | 1.70379527 |
| 135 | Metaphyseal irregularity (HP:0003025) | 1.67308778 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 1.66820376 |
| 137 | Recurrent bronchitis (HP:0002837) | 1.65365034 |
| 138 | Dementia (HP:0000726) | 1.62693501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TBK1 | 4.00112493 |
| 2 | MAP3K14 | 3.85659765 |
| 3 | RIPK4 | 3.74621254 |
| 4 | ERN1 | 3.64790519 |
| 5 | TYK2 | 3.61605713 |
| 6 | BLK | 3.10177234 |
| 7 | IKBKE | 3.00372387 |
| 8 | IRAK4 | 2.87223786 |
| 9 | PIM2 | 2.72951536 |
| 10 | MAP4K1 | 2.50198418 |
| 11 | IRAK3 | 2.37376281 |
| 12 | IKBKB | 2.30906243 |
| 13 | JAK1 | 2.28040884 |
| 14 | KIT | 2.18234923 |
| 15 | JAK3 | 2.01731336 |
| 16 | PBK | 1.98462082 |
| 17 | TXK | 1.83787758 |
| 18 | CSK | 1.77816535 |
| 19 | FGR | 1.77527334 |
| 20 | LIMK1 | 1.77252452 |
| 21 | MATK | 1.76596494 |
| 22 | TGFBR2 | 1.67660951 |
| 23 | RPS6KA4 | 1.67148681 |
| 24 | STK16 | 1.57455978 |
| 25 | MAPK7 | 1.55856626 |
| 26 | FES | 1.52454897 |
| 27 | CDC42BPA | 1.51689804 |
| 28 | PDK2 | 1.45924011 |
| 29 | MAP3K3 | 1.41647580 |
| 30 | CHUK | 1.41449601 |
| 31 | ABL2 | 1.34529895 |
| 32 | MAP3K5 | 1.32864527 |
| 33 | EPHB1 | 1.31435634 |
| 34 | MAP3K10 | 1.31381376 |
| 35 | BMX | 1.29591512 |
| 36 | GRK5 | 1.20987091 |
| 37 | TAOK2 | 1.20563007 |
| 38 | HCK | 1.18861946 |
| 39 | MAP3K13 | 1.15856351 |
| 40 | MAPK15 | 1.10874075 |
| 41 | RIPK1 | 1.10735213 |
| 42 | BMPR1B | 1.07343252 |
| 43 | SYK | 1.05388105 |
| 44 | NEK9 | 1.04803764 |
| 45 | IRAK1 | 1.04368140 |
| 46 | BMPR2 | 1.03766544 |
| 47 | SCYL2 | 1.01057807 |
| 48 | IRAK2 | 0.99530841 |
| 49 | ZAP70 | 0.99526453 |
| 50 | NEK6 | 0.99235286 |
| 51 | FGFR4 | 0.97268006 |
| 52 | LYN | 0.96032823 |
| 53 | STK10 | 0.93096225 |
| 54 | CSF1R | 0.92963493 |
| 55 | ITK | 0.92528716 |
| 56 | MARK3 | 0.92029985 |
| 57 | DDR2 | 0.91904367 |
| 58 | JAK2 | 0.91677294 |
| 59 | LCK | 0.91586697 |
| 60 | MAP2K3 | 0.91343197 |
| 61 | EIF2AK2 | 0.86809241 |
| 62 | MYLK | 0.83041071 |
| 63 | LATS2 | 0.82726054 |
| 64 | DAPK3 | 0.82328537 |
| 65 | MAP2K2 | 0.81973120 |
| 66 | NME2 | 0.81651849 |
| 67 | MST1R | 0.81196570 |
| 68 | TTN | 0.80791266 |
| 69 | PIM1 | 0.80271719 |
| 70 | MST4 | 0.80211057 |
| 71 | PRPF4B | 0.79926634 |
| 72 | MAP3K11 | 0.76745208 |
| 73 | EGFR | 0.74923135 |
| 74 | PKN1 | 0.74028058 |
| 75 | MOS | 0.72451462 |
| 76 | EPHA3 | 0.72347776 |
| 77 | ARAF | 0.69317953 |
| 78 | RPS6KA2 | 0.68648123 |
| 79 | PRKCD | 0.66235452 |
| 80 | TEC | 0.65650149 |
| 81 | MAP3K6 | 0.65590448 |
| 82 | CAMK1D | 0.65090137 |
| 83 | PDPK1 | 0.64701790 |
| 84 | NLK | 0.64633402 |
| 85 | ABL1 | 0.63821947 |
| 86 | CDK6 | 0.63096066 |
| 87 | SIK2 | 0.62835642 |
| 88 | HIPK2 | 0.61367280 |
| 89 | LRRK2 | 0.60507236 |
| 90 | MAPKAPK3 | 0.58611073 |
| 91 | PLK2 | 0.58433802 |
| 92 | YES1 | 0.58106763 |
| 93 | SGK3 | 0.58077016 |
| 94 | MAPKAPK5 | 0.57200315 |
| 95 | GRK7 | 0.56459515 |
| 96 | PDK1 | 0.55948047 |
| 97 | ROCK2 | 0.55171142 |
| 98 | IGF1R | 0.55065489 |
| 99 | CAMK2G | 0.54168189 |
| 100 | FGFR3 | 0.52577783 |
| 101 | TGFBR1 | 0.52490950 |
| 102 | MAP3K1 | 0.52100516 |
| 103 | TRPM7 | 0.51118653 |
| 104 | TAOK3 | 0.51071358 |
| 105 | PAK6 | 0.49663341 |
| 106 | CAMKK2 | 0.48878510 |
| 107 | EPHB2 | 0.47468835 |
| 108 | ERBB3 | 0.46957964 |
| 109 | BTK | 0.46859348 |
| 110 | PDGFRA | 0.46279440 |
| 111 | ERBB4 | 0.45955609 |
| 112 | PDGFRB | 0.43721796 |
| 113 | MAPK4 | 0.43359250 |
| 114 | PIK3CG | 0.42308151 |
| 115 | MAPK12 | 0.42157831 |
| 116 | KSR2 | 0.41939423 |
| 117 | SGK2 | 0.41854086 |
| 118 | PRKG1 | 0.41379188 |
| 119 | MAPKAPK2 | 0.41187844 |
| 120 | DYRK1B | 0.40988689 |
| 121 | RPS6KA6 | 0.39978833 |
| 122 | DAPK2 | 0.39867845 |
| 123 | TESK1 | 0.38261615 |
| 124 | STK3 | 0.37677534 |
| 125 | DMPK | 0.37020967 |
| 126 | ADRBK2 | 0.36327592 |
| 127 | INSR | 0.35760577 |
| 128 | GSK3A | 0.35505853 |
| 129 | PAK4 | 0.32600100 |
| 130 | FYN | 0.31525732 |
| 131 | PRKG2 | 0.30225252 |
| 132 | PTK2B | 0.26217156 |
| 133 | RPS6KC1 | 0.25312046 |
| 134 | RPS6KL1 | 0.25312046 |
| 135 | PTK6 | 0.24498713 |
| 136 | MAP3K2 | 0.24475075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.40279895 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.14594964 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.09109368 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.06362216 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.90799431 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.74541539 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.62186684 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51388375 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.46560801 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.40977531 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.33661831 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.31200163 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29186080 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.26476332 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.25160334 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.25096618 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.13324433 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.04995970 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 2.02033259 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.93655128 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.90572355 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.90006503 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88974934 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.80776313 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68054671 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.67915352 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62957050 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48106041 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47899135 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38924052 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37205185 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32943767 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32870973 |
| 34 | Amoebiasis_Homo sapiens_hsa05146 | 1.31505474 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27182239 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24070719 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.23995513 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.21456221 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21156867 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.20688204 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.19511007 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15570559 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.14609610 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 1.14037904 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07534832 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05581502 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96090436 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90484708 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88700750 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83704372 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.81775272 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81714487 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80682266 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80292628 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75409040 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73258594 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68899537 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.67574380 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66500353 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62829337 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62224355 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62087163 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61922553 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60260309 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59478051 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58485261 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57734950 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56064997 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55474857 |
| 70 | * Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53507874 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52501503 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51995414 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51599909 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51059958 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.48451287 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47820164 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45572419 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.44138280 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40237834 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38631677 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37569206 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37533287 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36585613 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36002232 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35888351 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35807268 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35466213 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35382579 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34613568 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33311082 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33240394 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32842969 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32556921 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32454114 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.32295065 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31337894 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31142616 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31065754 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.31062759 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30828184 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30180114 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29347328 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28937803 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.27087131 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26522374 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.26094648 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25434226 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25185608 |
| 109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24586567 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24164466 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.23870755 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23424172 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.23283458 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.22855305 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22802529 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22071116 |
| 117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.20945246 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.18924006 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.18007550 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17156806 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15817582 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15087435 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.13646391 |

